See the press release for more information. The new RONDO 2 processor also received FDA approval, but it is not compatible with N22 implants. Cochlear continues to support its legacy users by making the latest technology available to the greatest extent possible.
The Nucleus 7 processor has received FDA approval for N22 recipients. And it appears they will be somewhat smaller than the current Q series processors.
Kanso 2 processor android#
But based on sister company Phonak’s Marvel line of hearing aids, the M series will likely include direct wireless streaming from both Android and iPhones.
More information is sure to be coming from Advanced Bionics. The accented character isn’t in the FCC documentation, but the assumption is that it will mirror the current family of processors. The three processors are identified as Naída CI M30, Naída CI M60, and Sky CI M90. According to the report, there will be three versions, presumably offered in different markets around the world, and with different feature sets. The United States Federal Communications Commission has approved the radio-frequency components of a new family of processors from Advanced Bionics. Exciting news is on the way from Advanced Bionics, Cochlear, and MED-EL! AB and MED-EL are on the verge of introducing new processors, and Cochlear is making the Nucleus 7 and Kanso 2 processors available to N22 recipients.
0 kommentar(er)
